(Q62513697)
Statements
Lanreotide treatment of metastatic hepatocellular carcinoma resulting in partial regression and more than 3 years of progression-free survival (English)
Ivan Borbath
Renaud Lhommel
Yves Guiot
Emmanuel Coche
scientific article published on 01 June 2012